These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33792894)

  • 21. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.
    Brett J; Austoker J
    J Public Health Med; 2001 Dec; 23(4):292-300. PubMed ID: 11873891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Between-Race Differences in Supplemental Breast Cancer Screening Before and After Breast Density Notification Law.
    Manning M; Albrecht TL; O'Neill S; Purrington K
    J Am Coll Radiol; 2019 Jun; 16(6):797-803. PubMed ID: 30342908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of non attendance to mammography program in a region with high voluntary health insurance coverage.
    Esteva M; Ripoll J; Leiva A; Sánchez-Contador C; Collado F
    BMC Public Health; 2008 Nov; 8():387. PubMed ID: 19014522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer screening in an insured population: whom are we missing?
    Kempe KL; Larson RS; Shetterley S; Wilkinson A
    Perm J; 2013; 17(1):38-44. PubMed ID: 23596367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of Screening Mammogram Cancellations During COVID-19.
    Pairawan SS; Olmedo Temich L; de Armas S; Folkerts A; Solomon N; Cora C; Ramalingam K; Lum SS
    Am Surg; 2021 Dec; 87(10):1651-1655. PubMed ID: 34628958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of a pre-scheduled appointment on attendance in a population-based mammography screening programme.
    Goossens MM; Kellen E; Broeders MJM; Vandemaele E; Jacobs B; Martens P
    Eur J Public Health; 2023 Dec; 33(6):1122-1127. PubMed ID: 37555832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective assessment of racial/ethnic differences in future mammography behavior among women who had early mammography.
    Kapp JM; Walker R; Haneuse S; Yankaskas BC
    Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):600-8. PubMed ID: 21242330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial and age-related disparities in obtaining screening mammography: results of a statewide database.
    Jazieh AR; Buncher CR
    South Med J; 2002 Oct; 95(10):1145-8. PubMed ID: 12425498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in breast cancer screening in Missouri from 1987 to 1995, and predictions for the years 2000 and 2010.
    Sarr M; Simoes EJ; Murayi T; Figgs LT; Brownson RC
    Mo Med; 1998 Dec; 95(12):663-9. PubMed ID: 9863343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engaging diverse underserved communities to bridge the mammography divide.
    Engelman KK; Cupertino AP; Daley CM; Long T; Cully A; Mayo MS; Ellerbeck EF; Geana MV; Greiner A
    BMC Public Health; 2011 Jan; 11():47. PubMed ID: 21255424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening mammogram utilization in women with diabetes.
    Beckman TJ; Cuddihy RM; Scheitel SM; Naessens JM; Killian JM; Pankratz VS
    Diabetes Care; 2001 Dec; 24(12):2049-53. PubMed ID: 11723081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
    Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
    AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
    [No Abstract]   [Full Text] [Related]  

  • 34. Determining the spatial heterogeneity underlying racial and ethnic differences in timely mammography screening.
    Gibbons J; Schiaffino MK
    Int J Health Geogr; 2016 Nov; 15(1):39. PubMed ID: 27825351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delay in diagnostic testing after abnormal mammography in low-income women.
    Wujcik D; Shyr Y; Li M; Clayton MF; Ellington L; Menon U; Mooney K
    Oncol Nurs Forum; 2009 Nov; 36(6):709-15. PubMed ID: 19887359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States).
    May DS; Lee NC; Richardson LC; Giustozzi AG; Bobo JK
    Cancer Causes Control; 2000 Sep; 11(8):697-705. PubMed ID: 11065006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities in Breast Cancer Screening Between Caucasian and Asian American Women.
    Paranjpe A; Zheng C; Chagpar AB
    J Surg Res; 2022 Sep; 277():110-115. PubMed ID: 35489215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health beliefs and illness perceptions as related to mammography uptake in randomly selected women in Greece.
    Anagnostopoulos F; Dimitrakaki C; Fitzsimmons D; Potamianos G; Niakas D; Tountas Y
    J Clin Psychol Med Settings; 2012 Jun; 19(2):147-64. PubMed ID: 22108797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compliance With Screening Mammography Guidelines After a False-Positive Mammogram.
    Hardesty LA; Lind KE; Gutierrez EJ
    J Am Coll Radiol; 2016 Sep; 13(9):1032-8. PubMed ID: 27233908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of health beliefs on screening mammography utilization among a diverse sample of older women.
    Thomas LR; Fox SA; Leake BG; Roetzheim RG
    Women Health; 1996; 24(3):77-94. PubMed ID: 9046554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.